Update on new forms of tobacco use.

Autor: Gómez Cerezo JF; Servicio de Medicina Interna, Hospital Universitario Infanta Sofía, Madrid, España. Electronic address: jfrancisco.gomez@salud.madrid.org., López Paz JE; Presidente de la Sociedad Gallega de Hipertensión Arterial (SOGAHTA), A Coruña, España., Fernández Pardo J; Servicio de Medicina Interna, Hospital Universitario Reina Sofía, Murcia, España.
Jazyk: English; Spanish; Castilian
Zdroj: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis [Clin Investig Arterioscler] 2022 Nov-Dec; Vol. 34 (6), pp. 330-338. Date of Electronic Publication: 2022 May 21.
DOI: 10.1016/j.arteri.2022.03.004
Abstrakt: Smoking remains the leading cause of morbidity and mortality worldwide. Because of its clear influence on cardiovascular and respiratory diseases, it is an important factor in internal medicine consultations. Although the rate of smoking cessation has been increasing in recent years, there is a percentage of patients who continue to smoke because they are unable or unwilling to quit, despite having tried existing pharmacological and non-pharmacological therapies. For this group of patients there are strategies based on interventions aimed at reducing the negative effects of smoking without the need for complete cessation. In this review it is shown that due to the absence of combustion of organic matter in conventional cigarettes, snus, e-cigarettes and heated tobacco products generate significantly lower levels of toxic substances.
(Copyright © 2022 The Author(s). Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE